American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy.

Keedy VL, Temin S, Somerfield MR, Beasley MB, Johnson DH, McShane LM, Milton DT, Strawn JR, Wakelee HA, Giaccone G
J Clin Oncol. 2011 29 (15): 2121-7

PMID: 21482992 · DOI:10.1200/JCO.2010.31.8923

MeSH Terms (11)

Carcinoma, Non-Small-Cell Lung Clinical Trials, Phase III as Topic DNA Mutational Analysis ErbB Receptors Health Planning Guidelines Humans Lung Neoplasms Mutation Protein Kinase Inhibitors Randomized Controlled Trials as Topic Societies, Medical

Connections (1)

This publication is referenced by other Labnodes entities: